Medicare Enrolled

Dr. Ann-Margaret Ochs, D. O.

Hematology & Oncology · Weatherford, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
911 FOSTER LN, Weatherford, TX 76086
8175977900
In practice since 2006 (19 years)
NPI: 1710917083 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ochs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ochs? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ochs

Dr. Ann-Margaret Ochs is a hematology & oncology specialist in Weatherford, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ochs performed 132,256 Medicare services across 3,025 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ochs received a total of $897 from 23 pharmaceutical and/or device companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ochs is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 4% volume in TX $897 industry payments

Medicare Practice Summary

Medicare Utilization ↗
132,256
Medicare services
Top 4% in TX for hematology & oncology
3,025
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,961 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 57,120 $0 $5
Pembrolizumab injection (Keytruda) 22,900 $43 $137
Paclitaxel chemotherapy injection 10,536 $0 $8
Anti-nausea injection (fosaprepitant) 10,350 $0 $5
Immune globulin infusion (Octagam) 9,138 $34 $234
Denosumab injection (Prolia/Xgeva) 8,700 $18 $66
Epoetin alfa injection (Procrit) for anemia 1,830 $6 $51
Dexamethasone injection (steroid) 1,825 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 1,150 $1 $114
Blood draw (venipuncture) 901 $8 $20
Complete blood count (CBC) with differential 770 $8 $36
Injection, granisetron hydrochloride, 100 mcg 710 $0 $24
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 493 $22 $157
Injection, carboplatin, 50 mg 489 $2 $300
Administration of chemotherapy into vein, 1 hour or less 467 $97 $707
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 444 $47 $313
Office visit, established patient (30-39 min) 426 $93 $368
Comprehensive metabolic blood panel 420 $10 $64
Drug injection, under skin or into muscle 367 $10 $96
Injection, zoledronic acid, 1 mg 284 $6 $431
Injection, iron dextran, 50 mg 261 $14 $43
Injection, diphenhydramine hcl, up to 50 mg 233 $1 $7
Office visit, established patient (20-29 min) 230 $61 $250
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 175 $15 $100
Administration of chemotherapy into vein, each additional hour 152 $21 $161
Administration of additional new drug or substance into vein, 1 hour or less 127 $48 $344
Lactate dehydrogenase (enzyme) level 124 $6 $31
Injection of additional new drug or substance into vein 123 $11 $108
Leuprolide acetate (for depot suspension), 7.5 mg 109 $134 $3,675
Microscopic examination for white blood cells with manual cell count 104 $4 $22
Complete blood count (CBC), automated 104 $6 $34
Infusion, normal saline solution , 1000 cc 93 $2 $19
Magnesium level test 86 $7 $29
Unclassified drugs 86 $1 $8
Injection, magnesium sulfate, per 500 mg 84 $1 $6
Ferritin level test (iron stores) 70 $13 $60
Infusion into a vein for hydration, 31-60 minutes 69 $24 $256
Iron level test 68 $6 $27
Iron binding capacity test 68 $9 $35
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 67 $24 $145
New patient office visit (45-59 min) 62 $121 $565
Irrigation of implanted venous access drug delivery device 57 $18 $114
Basic metabolic blood panel 48 $8 $49
Uric acid level test 46 $4 $25
Infusion, normal saline solution, sterile (500 ml = 1 unit) 43 $1 $19
Immunoglobulin level test 38 $9 $56
Nuclear medicine study from skull base to mid-thigh with ct scan 37 $1,141 $4,802
Office visit, established patient, complex (40-54 min) 37 $133 $496
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 35 $90 $657
Drawing of blood for a medical problem 30 $61 $264
Infusion into a vein for hydration, each additional hour 25 $10 $75
Carcinoembryonic antigen (cea) protein level 21 $19 $99
New patient office visit (30-44 min) 13 $61 $372
New patient office visit, complex (60-74 min) 11 $168 $709
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.1% high complexity
45.8% medium
3.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$897
Total received (2018-2024)
Avg $149/year across 6 years
Bottom 27% in TX for hematology & oncology
23
Companies
36
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$862 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$235
2023
$209
2022
$111
2021
$12
2019
$51
2018
$280

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$118
Novartis Pharmaceuticals Corporation
$80
Stryker Corporation
$70
Celgene Corporation
$64
AstraZeneca Pharmaceuticals LP
$57
Puma Biotechnology, Inc.
$53
GENZYME CORPORATION
$46
PFIZER INC.
$43
Monteris Medical Corporation
$35
Janssen Biotech, Inc.
$31
Genentech USA, Inc.
$31
ABBVIE INC.
$27
Astellas Pharma US Inc
$27
EISAI INC.
$24
E.R. Squibb & Sons, L.L.C.
$23
Gilead Sciences, Inc.
$23
Karyopharm Therapeutics Inc.
$23
Apellis Pharmaceuticals, Inc.
$23
Lilly USA, LLC
$22
GlaxoSmithKline, LLC.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Pharmacyclics LLC, An AbbVie Company
$20
Merck Sharp & Dohme Corporation
$15
Top 3 companies account for 29.9% of total payments
Associated products mentioned in payments ›
Avastin · BOSULIF · DARZALEX · Empaveli · Erleada · Fabhalta · IMBRUVICA · JAYPIRCA · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · Lenvima · NERLYNX · Nerlynx · Neuroblate · OJJAARA · OPTABLATE · REBLOZYL · SARCLISA · SUTENT · TECENTRIQ · VENCLEXTA · VOTRIENT · Vyloy · XALKORI · XPOVIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Weatherford?
Compare hematology & oncology specialists in the Weatherford area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
5
Per 100K population
3.2
County median income
$102,099
Nearest hospital
MEDICAL CITY WEATHERFORD
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ochs is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ochs experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ochs performed 57,120 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ochs receive payments from pharmaceutical companies?
Yes. Dr. Ochs received a total of $897 from 23 companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ochs's costs compare to other hematology & oncology specialists in Weatherford?
Dr. Ochs's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ochs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →